Various mouse models to study dengue have been described by different authors, some of them using immunodeficient or some using humanized mice. Our group reported previously a deadly murine model, which used the intracranial inoculum of highly virulent Dengue virus (DENV) in immune competent mouse. Here we present a model of immune competent mouse (C57BL/6), infected subcutaneously by the same highly virulent DENV (DENV3 genotype I). In this immunocompetent systemic mice model, the cytokine levels and hematological parameters such as total and differential leukocyte and platelets counts, together with weight loss, were considered important monitoring parameters, allowing a better understanding of the systemic human disease. Mice were inoculated subcutaneously and evaluated by the percentage weight variation as well as the clinical signs. Hematological parameters and cytokines levels were measured and viral titration in brain tissue or serum neutralization was performed to confirm mice infection. The subcutaneously DENV inoculated mice showed weight loss after infection, but they did not show any other clinical signs. The leukocytes and platelets decreased after subcutaneous inoculation. The cytokines TNF alpha and IFN gamma increased after infection in mice. The subcutaneous model provided scope for improved understanding of the dengue pathogenesis, as well as possible mechanism for protection to subsequent mouse infected by intracranial route in mice. This model could be used to study the vertebrate immune response and evaluation of drugs or vaccine against dengue virus.
Introduction
Dengue, one of the most prevalent infectious diseases in the 21 st century [1] , is a mosquito-borne viral disease. Dengue is a febrile disease of acute evolution caused by the dengue virus (DENV) of the Flaviviridae family, and it infects humans through the bite of the female hematophagous mosquito Aedes aegypti [2] . Patients often develop a sudden high fever after the incubation period. This acute febrile phase usually lasts 2 -7 days and is often accompanied by several symptoms, such as headaches, chills, retro-orbital pain, and myalgia. Dengue was classified by the World Health Organization as occurring with or without warning signs or as severe dengue [3] [4].
One of the possible warning signs is the impairing of consciousness (neurological disease) caused by DENV, which may include symptoms such as severe headache, neck stiffness, reduced consciousness and seizures. Although not very common to date, neurological disease caused by DENV is more frequently described in the last years and is a severe disease. However, the cause of this neurovirulence is still unclear [5] [6] [7] [8] [9] . In animal model, the uses of hematological parameters such as differentiation and counting of total leukocytes, red blood cells, platelets, lymphocytes, neutrophils and monocytes [10] [11] [12] [13] are important disease markers, allowing a better understanding of dengue disease and its response mechanisms in the body of the animals studied [5] [14] [15] [16] [17] . Additionally, cytokines such as IFN gamma, TNF alpha and IL12p70 are used to evaluate the immune response to DENV infection [18] [19] [20] .
Three different approaches are found in the literature, focusing on the induction of a human-like disease in any of: 1) immunocompetent mice [6] , 2) mice deficient in specific genes that are important for the immune response and are naturally absent or have been removed [17] [21] [22] , and 3) immunodeficient mice that had been implanted with human cells [6] [21] [22] .
Our group reported previously an intracranial inoculum of a highly virulent DENV in immune competent mouse, causing death [6] . However, this model was very aggressive with the death of the mice in 9 days with neurological signs.
Here we present a model of immune competent mouse (C57BL/6) infected subcutaneously mimicking the natural way of infection by the same highly virulent DENV (DENV3 genotype I) used previously [6] [21] . This allowed the understanding of some additional steps of the pathogenesis, and showed that the subcutaneous infection conferred protection to a second infection by an intracranial via.
Material and Methods

Virus
DENV3 genotype I (MG20), which is highly virulent for mice, was obtained from virus collection of Laboratório de Vírus of Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil. It was isolated from a patient presenting neurological manifestations of dengue and death [23] . The virus used in this study was a virus with only 6 passages in C6/36 cells, thus maintaining the initial highly virulent characteristics of the virus.
Cells
C6/36 cells is a continuous lineage obtained from Aedes albopictus (ATCC, number CRL-1660) larvae and were cultivated on Leibovitz (L-15) medium (Gibco, USA), containing ciprofloxacin at 10 μg/mL and fetal bovine serum (FBS) at 10% (Cultilab, Brazil). Cells were maintained in BOD at 28˚C. For the passage of cell monolayers, culture medium was discarded and cells washed with phosphate buffer saline (PBS), pH 7,2 and then homogenized in L15 medium (Gibco, USA) and distributed into 25 or 75 cm 2 culture flasks. C6/36 cells were used to study viral replication. BHK-21 cells derived from hamster kidney (ATCC, number CCL-10) were cultivated on Dulbecco's Modified Eagle Medium (DMEM, Gibco, USA), containing gentamicin at 50 μg/mL, penicillin at 100 IU/mL, amphotericin B at 5 μg/mL and FBS at 5%. Cells were maintained in a CO 2 cell incubator at 37˚C. BHK cells were used in viral titration protocol and serum neutralization test.
Mice
Immune competent C57BL/6 mice were provided by animal facilities of Instituto René Rachou-Fiocruz-MG (IRR). The animals, all males, were 8 weeks old.
Animal Research
This project was submitted to and approved by the Ethical Committee of Animal Handling (CEUA) from Fundação Oswaldo Cruz, Fiocruz, Brazil (LW-7/16), see annex 1. This study was carried out in strict accordance with the recommendations of the Brazilian National Council for Control of Animal Research (CONCEA).
Criteria Used to Determine Mice Euthanasia
In previous publication we demonstrated that mice inoculated by intracranial route with highly virulent virus presented clinical signs of disease as loss of weight, lethargy, ruffled fur, hunched posture and paralysis of paws, and since then it has been established by our group that the mice with these clinical signs should be immediately euthanized [6] . These criteria were described in the project submitted and approved by the Ethical Committee of Animal Handling described above.
Additionally the infected or mock mice were euthanized at the end of each experiment. No animal died before meeting the euthanasia criteria or before the end of the experiment.
Animal Welfare
Animals were maintained in micro isolators on ventilated shelves at IRR's animal facilities, where the temperature (23˚C ± 2˚C), humidity, ventilation, sanitation and illumination were controlled. Food and water were provided ad libitum. 
Models of Infection
Viral Titration
BHK-21 cells were used to titer viral stocks and the organs of infected mice. Cell monolayer, 5 × 10 5 BHK-21 cells were implanted in 6 wells plates with DMEM supplemented with 5% of heat inactivated FBS (Cultilab, Brazil) and antibiotics, and incubated for 24 hours at 37˚C in a 5% CO 2 cell incubator. Medium was discarded and cell monolayer was washed once with PBS. Then 400 μL of serial dilutions (using 10 −3 to 10 −7 dilutions) of virus to be titrated were added in each well, leaving a well for cell control. After one hour of adsorption the medium was removed and 2 mL/well of DMEM, containing 1% of carboxymethylcellulose (CMC) (Sigma, Germany) and 2% of FBS was added. Cells were incubated at 37˚C for 6 days at a cell incubator with 5% of CO 2 . After 6 days of observation under a microscope, cells were fixed for 1 hour with formaldehyde at 3.7% diluted in PBS for subsequent staining with crystal violet at 1% solution for 20
minutes. The number of lysed plaques were counted for titer determination in plaque forming units per milliliter (p.f.u./mL).
Plaque Reduction Neutralization Test (PRNT50) for DENV-3
The adapted protocol from Russell et al. [24] was used for serum neutralization 
Cytokine Level Detection
To measure the cytokine levels in brain tissues were collected, macerated and 
Blood Cells Count
Immediately after anesthesia, blood samples were obtained through brachial 
Statistical Analysis
The infected groups were compared to the control group using the Mann-Whitney test for non-parametric samples and T-test for parametric samples. Statistical analyzes were performed utilizing the statistical software GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA). Differences were considered significant when p < 0.05.
Results
Impact on Weight after Inoculation of DENV3 Genotype I, By Subcutaneous (SC) Route and Protection to a Second Challenge by Intracranial (IC) Route of Infection in Immune Competent Mice
The C57BL/6 mice were inoculated via intracranial (IC) route with 4 × 10 2 p.f.u.
of DENV 3 genotype I (Figure 1 ). Clinical signs (weight loss, pilo-erection, hunched posture and hind limb paralysis) were evaluated daily, confirming the susceptibility to neuro-infection of mice by via intracranial (IC) route which developed neuro-encephalitis and death within 9 days after infection, as reported previously [6] . In another model, the same highly virulent DENV and the same strain of mice used in previous studies but inoculated subcutaneously (SC) DOI: 10.4236/jbm.2018.65011 (Table   1 ). There was an antibody response against DENV in the SC infection at a titer of 1:80 per mL at the 60 th day post infection (Table 1) .
Changes in Hematological Parameters
Leukopenia was observed in subcutaneously infected mice on the 8 th day after infection when compared to uninfected animals ( Figure 3(a) ). There was no significant difference in erythrocytes counts in mice (Figure 3(b) ) in any of the times studied when compared to the uninfected ones. Figure 3 (c) shows a decrease in the number of platelets at all times studied in the infected mice when compared to the uninfected mice. There was no difference in lymphocytes counts in infected mice, when compared to noninfected mice (Figure 4(a) ). A decrease in the monocytes count was observed 6 hours after infection in mice, when compared to non-infected mice (Figure 4(b) ). In the infected mice there was no difference in the neutrophils count in comparison to the uninfected mice, at the times studied (Figure 4(c) ). 
Cytokine Levels Increase in the Liver and Spleen of Mice after Subcutaneous Infection
An increase of TNF alpha level in mice spleen, 6 hours after subcutaneous DENV inoculation was observed, when compared to the uninfected group ( Figure 5(a) ). An increase of TNF alpha level in mice liver was observed 6 and 12 hours after subcutaneous DENV infection, when compared to the uninfected group ( Figure 5(b) ). The cytokine IL-12p70 in the liver of infected mice was similar to cytokine level found in uninfected mice at all times studied ( Figure   5(c) ). On the other side, IFN gamma in the liver of mice 6 and 12 hours after infection with DENV was increased, when compared to the uninfected mice ( Figure 5(d) ). In the spleen no IL12-p70 and IFN gamma were detected (data not shown).
Discussion
Recently, our group presented an experimental model of intracranial (IC) infection with a highly virulent DENV, to study dengue disease with neurologic com- 
Conclusion
The study presents an immune competent mice model infected by via subcutaneous with highly virulent DENV. In this model, the cytokine levels and hematological parameters such as global and differential leukocyte and platelets counts, together with weight loss, were considered important parameters, allowing a better understanding of the disease, because these changes occur normally in human beings. Although there are other murine models for the study of
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dengue, none of them shows all characteristics of human disease. Therefore, more than one model to cover several aspects of the disease is necessary. Our model proved to be an effective and less invasive option for studying the effects of highly virulent DENV on the immune response. This model could be used to study the vertebrate immune response, drugs or vaccine against dengue virus as it reproduces some of the clinical symptoms of patients.
